Diagnosis and Treatment Management in Patients with Autoimmune Neutropenia
Archives of Medical Laboratory Sciences,
Vol. 5 No. 3 (2019),
1 Tir 2019
,
Page 1-9
https://doi.org/10.22037/amls.v5i3.30970
Abstract
Autoimmune neutropenia (AIN) is the frequent cause of neutropenia in infants and children. AIN is associated with a reduced neutrophil count, which is due to aberrant cell-mediated or humoral immune response. In this review, we will discuss the available diagnostic approaches and management of the diseases. We collected data from PubMed, Google Scholar, Medline, Web of Science databases, using a group of key words, such as neutropenia, autoimmune, diagnosis and management from 2000 until 2019. The most important aspects of primary assessment in the affected children were family history and physical examinations. Diagnostic methods in this disease are granulocyte indirect agglutination test (GAT) and granulocyte immunofluorescence test (GIFT). However, the sensitivity and specificity of these tests are low. In these patients, injection of granulocyte-colony stimulating factor (G-CSF), is the first line of treatment. Despite low prevalence, autoimmune neutropenia is a clinically significant disease and it is critical to identify it and pursue effective treatment in these patients.
- Autoimmune Neutropenia
- Diagnosis
- Treatment
- Granulocyte-Colony Stimulating Factor
- G-CSF
How to Cite
References
Newburger PE, Dale DC, editors. Evaluation and management of patients with isolated neutropenia. Seminars in hematology; 2013: Elsevier.
Dinauer M. The phagocyte system and disorders of granulopoiesis and granulocyte function. Nathan and Oski's hematology of infancy and childhood. 1998:889-967.
Newburger PE. Autoimmune and other acquired neutropenias. Hematology 2014, the American Society of Hematology Education Program Book. 2016; 2016(1):38-42.
Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood, The Journal of the American Society of Hematology. 1998;91(1):181-6.
Bruin M, Dassen A, Pajkrt D, Buddelmeyer L, Kuijpers T, De Haas M. Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course. Vox sanguinis. 2005; 88(1):52-9.
Lyall E, Lucas G, Eden O. Autoimmune neutropenia of infancy. Journal of clinical pathology. 1992; 45(5):431-4.
Farruggia P, Fioredda F, Puccio G, Porretti L, Lanza T, Ramenghi U, et al. Autoimmune neutropenia of infancy: Data from the I talian neutropenia registry. American journal of hematology. 2015; 90(12):E221-E2.
Wang LY, Wang CL, Chu CC, Lee HL, Ho HT, Liang DC, et al. Primary autoimmune neutropenia in children in Taiwan. Transfusion. 2009; 49(5):1003-6.
Farruggia P, Dufour C. Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians. Therapeutic advances in hematology. 2015;6(1):15-24.
Taniuchi S, Masuda M, Hasui M, Tsuji S, Takahashi H, Kobayashi Y. Differential diagnosis and clinical course of autoimmune neutropenia in infancy: comparison with congenital neutropenia. Acta Paediatrica. 2002; 91(11):1179-82.
Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatric Clinics. 2013; 60(6):1489-511.
Shastri KA, Logue GL. Autoimmune neutropenia [see comments]. 1993.
Sebastian S, Ashton K, Houston Y, Diggory TM, Dore P. Anti-TNF therapy induced immune neutropenia in Crohns disease-report of 2 cases and review of literature. Journal of Crohn's and Colitis. 2012;6(6):713-6.
Bruin MC, von dem Borne AEK, Tamminga RY, Kleijer M, Buddelmeijer L, de Haas M. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood, The Journal of the American Society of Hematology. 1999; 94(5):1797-802.
Bussel JB, Abboud MR. Autoimmune neutropenia of childhood. Critical reviews in oncology/hematology. 1987;7(1):37-51.
Dufour C, Miano M, Fioredda F. Old and new faces of neutropenia in children. Haematologica. 2016; 101(7):789.
Dale DC. How I manage children with neutropenia. British journal of haematology. 2017; 178(3):351-63.
Afzal W, Owlia MB, Hasni S, Newman KA. Autoimmune Neutropenia Updates: Etiology, Pathology, and Treatment. Southern medical journal. 2017; 110(4):300-7.
Fioredda F, Calvillo M, Burlando O, Riccardi F, Caviglia I, Tucci F, et al. Infectious complications in children with severe congenital, autoimmune or idiopathic neutropenia: a retrospective study from the Italian Neutropenia Registry. The Pediatric infectious disease journal. 2013; 32(4):410-2.
Capsoni F, Sarzi-Puttini P, Zanella A. Primary and secondary autoimmune neutropenia. Arthritis research & therapy. 2005;7(5):208.
Nossent J, Swaak A. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. QJM: An International Journal of Medicine. 1991; 80(1):605-12.
Starkebaum G, Arend W. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus. The Journal of clinical investigation. 1979; 64(4):902-12.
Dale DC, Welte K. Cyclic and chronic neutropenia. Hematopoietic Growth Factors in Oncology: Springer; 2010. p. 97-108.
Stroncek D. Granulocyte gene polymorphisms and mutations: effects on immune response and neutrophil proliferation. Vox sanguinis. 2004; 87:101-4.
Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, et al. Stable long‐term risk of leukaemia in patients with severe congenital neutropenia maintained on G‐CSF therapy. British journal of haematology. 2010; 150(2):196-9.
Andrès E, Zimmer J, Affenberger S, Federici L, and Alt M, Maloisel F. Idiosyncratic drug-induced agranulocytosis: Update of an old disorder. European journal of internal medicine. 2006; 17(8):529-35.
Boxer LA, Greenberg MS, Boxer GJ, Stossel TP. Autoimmune neutropenia. New England Journal of Medicine. 1975; 293(15):748-53.
Hadley AG, Holburn A, Bunch C, Chapel H. Anti‐granulocyte opsonic activity and autoimmune neutropenia. British journal of haematology. 1986; 63(3):581-9.
Simpson DM, Ross R. Effects of heterologous antineutrophil serum in guinea pigs: Hematologic and ultrastructural observations. The American journal of pathology. 1971; 65(1):79.
Bux J, Chapman J. Report on the second international granulocyte serology workshop. Transfusion. 1997; 37(9):977-83.
Farruggia P. Immune neutropenias of infancy and childhood. World Journal of Pediatrics. 2016; 12(2):142-8.
Heinzl M, Schönbacher M, Dauber EM, Panzer S, Mayr W, Körmöczi G. Detection of granulocyte‐reactive antibodies: a comparison of different methods. Vox sanguinis. 2015; 108(3):287-93.
Dungarwalla M, Marsh J, Tooze J, Lucas G, Ouwehand W, Pettengell R, et al. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Annals of hematology. 2007; 86(3):191-7.
Fioredda F, Calvillo M, Bonanomi S, Coliva T, Tucci F, Farruggia P, et al. Congenital and acquired neutropenias consensus guidelines on therapy and follow‐up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato‐Oncologia Pediatrica). American journal of hematology. 2012; 87(2):238-43.
Celkan T, Koç BŞ. Approach to the patient with neutropenia in childhood. Turkish Archives of Pediatrics/Türk Pediatri Arşivi. 2015;50(3):136.
- Abstract Viewed: 278 times
- pdf Downloaded: 159 times